COVID-19 Related Dermatoses
Home
/
News
-
Residents
- Why ABFAS Board Certification?
- Pathway to Certification
- My Exam Pathway
- Residency In-training Exams
- In-training Examination Dates
- Didactic Exam Preparation
- CBPS Exam Preparation
- Resident Fees and ITE Conversion
- Residency Directors
- New Certification Process, Effective September 2020
- Resident Newsletters
- Resident FAQs
- Become Board Qualified
-
Become Board Certified
- Why ABFAS Board Certification?
- Pathway to Certification
- My Exam Pathway
- Board Certification Process
- Part II Case Review Overview
- NEW CBPS Overview (Board Qualified Before Fall 2020)
- Advertising Policies
- Fees
- New Certification Process, Effective September 2020
- Board Qualified Newsletters
- Candidate FAQs
- Diplomates
- Credentialers Only
- ABFAS Media
The American Academy of Dermatology is studying the dermatologic manifestations of the COVID-19 virus and needs your help. The association is asking all health care professionals who have provided care for COVID-19 patients who develop dermatologic manifestations and/or dermatology patients with an existing condition who develop COVID-19 to fill out this survey.
This registry is a collaborative effort and depends on the active participation from the international healthcare community. Please share this site with your colleagues and encourage them to report any cases of COVID-19 dermatoses.